These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11696645)

  • 1. Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies.
    Van de Wiele C; Dumont F; Dierckx RA; Peers SH; Thornback JR; Slegers G; Thierens H
    J Nucl Med; 2001 Nov; 42(11):1722-7. PubMed ID: 11696645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and dosimetry of (99m)Tc-depreotide (P829) in patients suffering from breast carcinoma.
    Van Den Bossche B; D'haeninck E; Bacher K; Thierens H; Van Belle S; Dierckx RA; Van de Wiele C
    Cancer Biother Radiopharm; 2004 Dec; 19(6):776-83. PubMed ID: 15665627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and dosimetry of (iodine-123)-iodomethyl-N, N-diethyltamoxifen, an (anti)oestrogen receptor radioligand.
    Van de Wiele C; De Vos F; De Sutter J; Dumont F; Slegers G; Dierckx RA; Thierens H
    Eur J Nucl Med; 1999 Oct; 26(10):1259-64. PubMed ID: 10541823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Pichardo-Romero PA
    Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imaging.
    Rijks LJ; Busemann Sokole E; Stabin MG; de Bruin K; Janssen AG; van Royen EA
    Eur J Nucl Med; 1998 Jan; 25(1):40-7. PubMed ID: 9396873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry.
    Van de Wiele C; Phonteyne P; Pauwels P; Goethals I; Van den Broecke R; Cocquyt V; Dierckx RA
    J Nucl Med; 2008 Feb; 49(2):260-4. PubMed ID: 18199617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
    Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
    Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution and dosimetry of 99mTc-ciprofloxacin, a promising agent for the diagnosis of bacterial infection.
    De Winter F; Van de Wiele C; Dumont F; Van Durme J; Solanki K; Britton K; Slegers G; Dierckx RA; Thierens H
    Eur J Nucl Med; 2001 May; 28(5):570-4. PubMed ID: 11383860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study.
    Van de Wiele C; Dumont F; Vanden Broecke R; Oosterlinck W; Cocquyt V; Serreyn R; Peers S; Thornback J; Slegers G; Dierckx RA
    Eur J Nucl Med; 2000 Nov; 27(11):1694-9. PubMed ID: 11105826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
    Grimes J; Celler A; Birkenfeld B; Shcherbinin S; Listewnik MH; Piwowarska-Bilska H; Mikolajczak R; Zorga P
    J Nucl Med; 2011 Sep; 52(9):1474-81. PubMed ID: 21795364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
    Nock BA; Cescato R; Ketani E; Waser B; Reubi JC; Maina T
    J Med Chem; 2012 Oct; 55(19):8364-74. PubMed ID: 22966957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.
    Mozley PD; Stubbs JB; Plössl K; Dresel SH; Barraclough ED; Alavi A; Araujo LI; Kung HF
    J Nucl Med; 1998 Dec; 39(12):2069-76. PubMed ID: 9867143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation Dosimetry of
    Urbán S; Meyer C; Dahlbom M; Farkas I; Sipka G; Besenyi Z; Czernin J; Calais J; Pávics L
    J Nucl Med; 2021 Aug; 62(8):1075-1081. PubMed ID: 33277398
    [No Abstract]   [Full Text] [Related]  

  • 16. Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.
    Iznaga-Escobar N; Torres LA; Morales A; Ramos M; Alvarez I; Pérez N; Fraxedas R; Rodríguez O; Rodríguez N; Pérez R; Lage A; Stabin MG
    J Nucl Med; 1998 Jan; 39(1):15-23. PubMed ID: 9443731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
    Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
    Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
    Nock B; Nikolopoulou A; Chiotellis E; Loudos G; Maintas D; Reubi JC; Maina T
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bombesin receptor antagonists may be preferable to agonists for tumor targeting.
    Cescato R; Maina T; Nock B; Nikolopoulou A; Charalambidis D; Piccand V; Reubi JC
    J Nucl Med; 2008 Feb; 49(2):318-26. PubMed ID: 18199616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and Internal Radiation Dosimetry of
    Song YS; Kim JH; Lee BC; Jung JH; Park HS; Kim SE
    Cancer Biother Radiopharm; 2018 Nov; 33(9):396-402. PubMed ID: 30133309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.